139 Real-World Outcomes of First-Line Chemo-Immunotherapy Versus Immunotherapy Monotherapy for Advanced Non-Small Cell Lung Cancer in the Post-COVID Era: A Single-Centre Service Evaluation

Lung Cancer 2026

View at publisher

Authors: Mohamed Sheeraz Mohamed Azhar, Ali Afzal, Poornima Jana, Abdul Mateen, Sameena Khan, Dr Meera Chauhan, Samreen Ahmed, Sean Dulloo

DOI: 10.1016/j.lungcan.2026.109088

Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers